JOEL PHILLIPS: Open Payments
NPI 1518367473 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 41 payments from 16 companies in 2025. Trend: 2023 $1,040 · 2024 $1,128 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $231 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Amgen Inc. | 5 | $74 |
| Esperion Therapeutics, Inc. | 4 | $74 |
| Lilly USA, LLC | 3 | $59 |
| Astellas Pharma US Inc | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| PFIZER INC. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Medtronic, Inc. | 1 | $27 |
Products named: Ozempic, OTEZLA, NEXLETOL, AIRSUPRA, Wegovy, ZEPBOUND, Veozah, PAXLOVID.
Industry payments across GA — which companies pay providers there.
